Allspring Global Investments’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-16
Closed -$249 – 2204
2024
Q3
$249 Buy
+16
New +$256 ﹤0.01% 2404
2023
Q3
– Sell
-2,018
Closed -$36.4K – 2865
2023
Q2
$36.4K Buy
2,018
+367
+22% +$6.86K ﹤0.01% 2361
2023
Q1
$27.7K Buy
1,651
+238
+17% +$4.66K ﹤0.01% 2445
2022
Q4
$29K Sell
1,413
-5,635
-80% -$99.4K ﹤0.01% 2493
2022
Q3
$134K Buy
7,048
+40
+0.6% +$899 ﹤0.01% 1965
2022
Q2
$164K Sell
7,008
-39,244
-85% -$1.12M ﹤0.01% 1881
2022
Q1
$1.51M Sell
46,252
-39,748
-46% -$1.28M ﹤0.01% 1652
2021
Q4
$2.67M Buy
+86,000
New +$2.88M ﹤0.01% 1406

Other funds holding OFIX

Allspring Global Investments's OFIX Position: Q4 2024 in Review

Allspring Global Investments sold out of Orthofix Medical (OFIX) in Q4 2024, closing a stake of 16 shares — an estimated $249 sold.

Allspring Global Investments first reported a position in OFIX in Q4 2021 and held it in 8 quarters. The position peaked at $2.67M in Q4 2021. 149 funds tracked by Wall St. Rank hold OFIX as of Q4 2024.

  • Allspring Global Investments reported no remaining Orthofix Medical position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 16 Orthofix Medical shares in Q4 2024, an estimated $249.
  • Allspring Global Investments first reported a position in Orthofix Medical in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's Orthofix Medical position peaked at $2.67M in Q4 2021.
  • 149 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.